Loading company…
Mountain View-based pharmaceutical company developing Anhydrix, an oral drug for primary focal hyperhidrosis.
Founded in 2005 and headquartered in Mountain View, US, TheraVida develops Anhydrix, a patent-protected oral drug for primary focal hyperhidrosis, which it aims to commercialize in the US market. The company raised USD 1.06 million in Series A funding in March 2012, with investors including Sanderling Ventures. It has completed two deals to date, with a current valuation of USD 25.755 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in